11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6201/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :16/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "METHOD FOR TREATING DISSEMINATED CANCER"<br />

(51) International classification :C12N 5/06 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :60/752,844<br />

1)SENTOCLONE AB<br />

(32) Priority Date :21/12/2005<br />

Address <strong>of</strong> Applicant :ALLEN 5, SE-17266 SUNDBYBERG,<br />

(33) Name <strong>of</strong> priority country :U.S.A.<br />

SWEDEN. Sweden<br />

(86) International Application No :PCT/EP2006/012305 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:20/12/2006<br />

1)OLA WINQVIST<br />

(87) International Publication No :WO 2007/071389 2)MAGNUS THORN<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention discloses an immunotherapeutic method for treating a patient suffering <strong>from</strong> a disseminated cancer by<br />

administering exp<strong>and</strong>ed tumour-reactive CD4+ helper <strong>and</strong>/or CD8+ T-lymphocytes obtainable <strong>from</strong> one or more metastasis-draining<br />

lymph nodes (metinel nodes) draining a metastasis. The method comprises identification <strong>of</strong> one or more metinel lymph nodes in a<br />

patient, resection <strong>of</strong> the one or more nodes <strong>and</strong>, optionally all or <strong>part</strong> <strong>of</strong> the metastases, isolation <strong>of</strong> metastasis-reactive T-lymphocytes<br />

<strong>from</strong> said lymph nodes, in vitro expansion <strong>of</strong> said metastasis-reactive T-lymphocytes, <strong>and</strong> administration <strong>of</strong> the thus obtained Tlymphocytes<br />

to the patient, wherein the T-lymphocytes are CD4+ helper <strong>and</strong>/or CD8+ T-lymphocytes.<br />

No. <strong>of</strong> Pages : 57 No. <strong>of</strong> Claims : 23<br />

The Patent Office Journal 24/10/2008 25747

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!